- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S3752
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other Amino Acids and Derivatives Products | (±)-Alliin L-Ornithine Aceglutamide Acetylleucine Selenomethionine 4-Aminohippuric Acid Afalanine (N-Acetyl-DL-phenylalanine) Tos-Arg-OMe HCl DL-O-Tyrosine L-5-Hydroxytryptophan |
|
In vitro |
Water : 26 mg/mL
DMSO
: Insoluble
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 131.17 | Formula | C6H13NO2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 73-32-5 | Download SDF Download SDF | Storage of Stock Solutions |
|
|
| In vitro |
Isoleucine plays a major role in enhancing glucose consumption and utilization by up-regulating intestinal and muscular glucose transporters. This compound could induce β-defensins’expressions in porcine intestinal epithelial cells.
|
|---|---|
| In vivo |
Isoleucine is beneficial for mammary health, milk quality and embryo growth, enhances intestinal development, intestinal amino acid transportation and mucin production and participates in up-regulating innate and adaptive immune responses. Studies in mice have indicated that diet-induced obesity mice in this compound treatment (final concentration of 2.5% isoleucine in drinking water) had almost 6% lower body weight gain and 49% less epididymal white adipose tissue mass compared with the control treatment, with higher levels of hepatic protein. Its deprivation induces fat mass loss in mice. This chemical could stimulate glucose uptake and participated in plasma glucose uptake in the rat.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06365268 | Not yet recruiting | Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region |
Assistance Publique - Hôpitaux de Paris |
May 2024 | -- |
| NCT06142513 | Not yet recruiting | Obesity Hypoventilation Syndrome|Obesity|Hypoventilation|Respiration Disorders|Sleep Disorder; Breathing-Related |
Istanbul University|Istanbul University - Cerrahpasa (IUC) |
April 10 2024 | -- |
| NCT05026047 | Not yet recruiting | Papillomavirus Infection |
Assistance Publique - Hôpitaux de Paris |
May 2023 | Not Applicable |
| NCT05812144 | Recruiting | Type 1 Facioscapulohumeral Muscular Dystrophy |
Centre Hospitalier Universitaire de Nice |
May 23 2023 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.